Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Cytokinetics (CYTK) has provided an update.
Cytokinetics, Incorporated has appointed Brett Pletcher as Executive Vice President and Chief Legal Officer, effective August 19, 2024. With a rich background in legal affairs at prestigious firms and companies, Pletcher brings seasoned expertise to the role. His compensation package includes a $560,000 annual base salary, with a bonus target of 45% and various incentive plans. Additionally, Pletcher will receive substantial initial equity awards that vest over time, subject to continued service with the company, and he’s set to receive a standard indemnification agreement from Cytokinetics.
See more insights into CYTK stock on TipRanks’ Stock Analysis page.
